Amneal Pharmaceuticals, Inc. AMRX Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s change in AR?
- Amneal Pharmaceuticals, Inc. (AMRX) reported change in AR of -$44.01M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s change in AR changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s change in AR decreased by 108.1% year-over-year, from -$21.15M to -$44.01M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s change in AR?
- Over 2 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s change in AR has grown at a 125.9% compound annual growth rate (CAGR), from $23.62M to $120.57M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.